Repligen | RGEN - Eigenkapital Und Reserven

Aktienkurs
118.31
Täglich Wechseln
5.20 4.60%
Monatlich
0.42%
Jährlich
-13.77%
Q2 Prognose
115.08




Eigenkapital Und Reserven Veränderung Datum
Agilent USD 6.91B 167M 2025-12
Align Technology USD 4.05B 91.69M 2025-12
Bio Techne USD 2.01B 45.18M 2025-12
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Bruker USD 2.49B 625.6M 2025-09
Charles River Laboratories USD 3.16B 240.82M 2025-12
Danaher USD 52.95B 415M 2026-03
Dentsply International USD 1.34B 139M 2025-12
General Electric Aerospace USD 18.06B 841M 2026-03
Henry Schein USD 3.24B 116M 2025-12
Illumina USD 2.72B 342M 2025-12
IQVIA Holdings USD 6.5B 343M 2025-12
Mettler Toledo International USD -23.64M 225.56M 2025-12
Myriad Genetics USD 368M 4.8M 2025-12
OraSure Technologies USD 340.83M 21.15M 2025-12
Pacific Biosciences Of California USD 5.35M 30.74M 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Repligen USD 2.11B 1.66B 2025-12
Revvity USD 7.38B 180.27M 2025-09
Standard Biotools USD 424.29M 24.63M 2025-12
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
Waters USD 2.56B 230.55M 2025-12
West Pharmaceutical Services USD 2.99B 185.6M 2026-03